Cytomegalovirus Retinitis [clinicaltrials_resource:7ea6ffb2d488a211750ed003c12429c3]
Ganciclovir Implant Study for Cytomegalovirus Retinitis [clinicaltrials:NCT00000118]clinicaltrials:NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) [clinicaltrials:NCT00000135]Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) [clinicaltrials:NCT00000136]Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) [clinicaltrials:NCT00000142]Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) [clinicaltrials:NCT00000143]Longitudinal Study of Ocular Complications of AIDS (LSOCA) [clinicaltrials:NCT00000168]Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [clinicaltrials:NCT00000665]A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir [clinicaltrials:NCT00000668]A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy [clinicaltrials:NCT00000673]A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00000688]A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure [clinicaltrials:NCT00000691]Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS [clinicaltrials:NCT00000693]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir [clinicaltrials:NCT00000697]A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis [clinicaltrials:NCT00000698]Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00000726]CMV Retinitis Retreatment Trial [clinicaltrials:NCT00000766]HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol [clinicaltrials:NCT00000799]A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) [clinicaltrials:NCT00000836]A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease [clinicaltrials:NCT00000881]Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis [clinicaltrials:NCT00000894]A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy [clinicaltrials:NCT00000905]A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir [clinicaltrials:NCT00000970]The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [clinicaltrials:NCT00000989]The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV [clinicaltrials:NCT00001034]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes [clinicaltrials:NCT00001062]Immune Activity Against CVM Retinitis [clinicaltrials:NCT00001611]A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS [clinicaltrials:NCT00001999]An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children [clinicaltrials:NCT00002015]A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis [clinicaltrials:NCT00002016]Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient [clinicaltrials:NCT00002025]A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS [clinicaltrials:NCT00002034]An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients [clinicaltrials:NCT00002039]Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [clinicaltrials:NCT00002070]A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) [clinicaltrials:NCT00002125]A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis [clinicaltrials:NCT00002134]An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access [clinicaltrials:NCT00002135]An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00002142]A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) [clinicaltrials:NCT00002156]
condition [clinicaltrials_vocabulary:condition]
Ganciclovir Implant Study for Cytomegalovirus Retinitis [clinicaltrials:NCT00000118]clinicaltrials:NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) [clinicaltrials:NCT00000135]Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) [clinicaltrials:NCT00000136]Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) [clinicaltrials:NCT00000142]Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) [clinicaltrials:NCT00000143]Longitudinal Study of Ocular Complications of AIDS (LSOCA) [clinicaltrials:NCT00000168]Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [clinicaltrials:NCT00000665]A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir [clinicaltrials:NCT00000668]A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy [clinicaltrials:NCT00000673]A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00000688]A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure [clinicaltrials:NCT00000691]Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS [clinicaltrials:NCT00000693]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir [clinicaltrials:NCT00000697]A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis [clinicaltrials:NCT00000698]Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00000726]CMV Retinitis Retreatment Trial [clinicaltrials:NCT00000766]HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol [clinicaltrials:NCT00000799]A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) [clinicaltrials:NCT00000836]A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease [clinicaltrials:NCT00000881]Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis [clinicaltrials:NCT00000894]A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy [clinicaltrials:NCT00000905]A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir [clinicaltrials:NCT00000970]The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [clinicaltrials:NCT00000989]The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV [clinicaltrials:NCT00001034]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes [clinicaltrials:NCT00001062]Immune Activity Against CVM Retinitis [clinicaltrials:NCT00001611]A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS [clinicaltrials:NCT00001999]An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children [clinicaltrials:NCT00002015]A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis [clinicaltrials:NCT00002016]Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient [clinicaltrials:NCT00002025]A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS [clinicaltrials:NCT00002034]An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients [clinicaltrials:NCT00002039]Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [clinicaltrials:NCT00002070]A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) [clinicaltrials:NCT00002125]A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis [clinicaltrials:NCT00002134]An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access [clinicaltrials:NCT00002135]An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00002142]A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) [clinicaltrials:NCT00002156]
condition browse [clinicaltrials_vocabulary:condition-browse]
Ganciclovir Implant Study for Cytomegalovirus Retinitis [clinicaltrials:NCT00000118]clinicaltrials:NCT00000134Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) [clinicaltrials:NCT00000135]Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) [clinicaltrials:NCT00000136]Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) [clinicaltrials:NCT00000142]Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) [clinicaltrials:NCT00000143]Longitudinal Study of Ocular Complications of AIDS (LSOCA) [clinicaltrials:NCT00000168]Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component [clinicaltrials:NCT00000665]A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir [clinicaltrials:NCT00000668]A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy [clinicaltrials:NCT00000673]A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00000688]A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure [clinicaltrials:NCT00000691]Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS [clinicaltrials:NCT00000693]A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir [clinicaltrials:NCT00000697]A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis [clinicaltrials:NCT00000698]Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00000726]CMV Retinitis Retreatment Trial [clinicaltrials:NCT00000766]HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol [clinicaltrials:NCT00000799]A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) [clinicaltrials:NCT00000836]A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease [clinicaltrials:NCT00000881]Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis [clinicaltrials:NCT00000894]A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy [clinicaltrials:NCT00000905]A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir [clinicaltrials:NCT00000970]The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS [clinicaltrials:NCT00000989]The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV [clinicaltrials:NCT00001034]Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS [clinicaltrials:NCT00001061]A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes [clinicaltrials:NCT00001062]Immune Activity Against CVM Retinitis [clinicaltrials:NCT00001611]A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS [clinicaltrials:NCT00001999]An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children [clinicaltrials:NCT00002015]A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis [clinicaltrials:NCT00002016]Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient [clinicaltrials:NCT00002025]A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS [clinicaltrials:NCT00002034]An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients [clinicaltrials:NCT00002039]Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis [clinicaltrials:NCT00002070]A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) [clinicaltrials:NCT00002125]A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis [clinicaltrials:NCT00002134]An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access [clinicaltrials:NCT00002135]An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS [clinicaltrials:NCT00002142]A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) [clinicaltrials:NCT00002156]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Cytomegalovirus Retinitis [clinicaltrials_resource:7ea6ffb2d488a211750ed003c12429c3]
Bio2RDF identifier
7ea6ffb2d488a211750ed003c12429c3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7ea6ffb2d488a211750ed003c12429c3
identifier
clinicaltrials_resource:7ea6ffb2d488a211750ed003c12429c3
title
Cytomegalovirus Retinitis
@en
type
label
Cytomegalovirus Retinitis [clinicaltrials_resource:7ea6ffb2d488a211750ed003c12429c3]
@en
Cytomegalovirus Retinitis